Z-2192-2013 Class II Terminated
FDA device recall Z-2192-2013 was initiated by Becton Dickinson & Company on Jul 10, 2013 and is designated Class II. Reason for recall: The Lancet will not retract after activation thus creating a potential for exposure to a used sharp. The recall status is terminated (terminated Mar 19, 2014). Affected quantity: US - 39,800 units ; Canada - 18,400 units.
Recall details
- Product Type
- Devices
- Report Date
- Sep 18, 2013
- Initiation Date
- Jul 10, 2013
- Termination Date
- Mar 19, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- US - 39,800 units ; Canada - 18,400 units
Product description
BD Microtainer Quikheel Lancet 1.0 mm incision Depth 2.5 mm Incision Length REF 368101 Rx Only Becton, Dickinson and Company, Franklin Lakes, NJ 07417 USA Made in USA. Used to perform heel sticks for the purpose of collecting skin puncture blood.
Reason for recall
The Lancet will not retract after activation thus creating a potential for exposure to a used sharp.
Distribution pattern
Distributed in the states of CT, KY, IL, NY, PA, TX, and VA and the country of Canada.
Code information
REF # 368101 Lot #3116007 Class I Exempt Device listing Number E158602
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2192-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026